A contract research organization (CRO) is a service provider, which offers end-to-end solutions in conducting clinical trials for biopharmaceutical and medical device companies. The core services offered by CROs to biopharmaceutical companies include initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services. At present, many pharmaceutical companies outsource their R&D activities to CROs and is expected that these companies will increase their outsourcing activities for drug the development process to CROs going forward.
The report delivers a strategic analysis of the global market for CROs, and growth forecast for the period from 2012 - 2020. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on the type of clinical trial phases and therapeutic areas. It also covers geographical analysis of the market with growth forecast for the period of 2012 - 2020. The Porter's Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.
The study also provides information for recent merger and acquisition deals which happened in the global CRO market. Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global CRO market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies.
The company profile section includes detailed analysis of some of the key players such as Covance, Inc., Quintiles Transnational Holdings Inc., PAREXEL International Corporation, PRA Health Sciences and PPD, Inc.